Đang chuẩn bị liên kết để tải về tài liệu:
Báo cáo y học: "Increased interleukin-23 receptor+ T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosu"
Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về y học được đăng trên tạp chí y học General Psychiatry cung cấp cho các bạn kiến thức về ngành y đề tài: Increased interleukin-23 receptor+ T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. | Puwipirom et al. Arthritis Research Therapy 2010 12 R215 http arthritis-research.eom content 12 6 R215 RESEARCH ARTICLE Open Access Increased interleukin-23 receptor T cells in peripheral blood mononuclear cells of patients with systemic lupus erythematosus Hathaipat Puwipirom 1 2 Nattiya Hirankarn1 2 3 Pimpayao Sodsai1 Yingyos Avihingsanon1 4 Jongkonnee Wongpiyabovorn1 2 3 Tanapat Palaga2 5 Abstract Introduction Systemic lupus erythematosus SLE is an autoimmune disorder characterized by production of autoantibodies and immune complex deposition in various organs. Aberrations in the T lymphocyte compartment and dysregulated cytokine production are key features of SLE pathogenesis and disease progression. Recently the role of the interleukin IL -17 IL-23 axis in the pathogenesis of SLE has been reported. IL-23 and IL-23R are essential for expansion of pathogenic IL-17-producing T lymphocytes and have been shown to be important in the pathogenesis of lupus in animal models. Methods In this study the expression of IL-23R and IL-17 in CD4 and CD8 T lymphocytes in peripheral blood mononuclear cells PBMCs of SLE patients and control subjects were examined by flow cytometry. Twenty-nine SLE patients and 10 control subjects were recruited in this study. Patients were divided into active and inactive groups based on the SLE disease activity index SLEDAI . As another disease control population five psoriatic patients were recruited in this study. Results Percentages of both IL23R CD4 and IL-23R CD8 T cell subsets were significantly higher in freshly isolated PBMCs from both groups of SLE patients compared to control subjects P 0.0021 and P 0.0006 respectively . In addition this difference was maintained after ex vivo stimulation with plate-bound anti-CD3 CD28 antibodies P 0.007 and P 0.0019 respectively . When the fold increase in IL-17 T cells after ex vivo stimulation for three days was compared between patients and controls SLE patients exhibited significantly higher .